Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001601485-25-000088
Filing Date
2025-05-20
Accepted
2025-05-20 16:07:13
Documents
1
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747771626.html 4  
1 FORM 4 wk-form4_1747771626.xml 4 4093
  Complete submission text file 0001601485-25-000088.txt   5637
Mailing Address C/O AYER CAPITAL MANAGEMENT, LP 230 CALIFORNIA ST, SUITE 600 SAN FRANCISCO CA 94111
Business Address
Venkatesan Jay (Reporting) CIK: 0001413350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 25968780

Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Issuer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)